Stay tuned and follow the latest developments and news in Molecular Oncology.
Driven by innovation and committed to improving cancer patient care, two powerful companies from Greece and North Macedonia are joining forces. The rapidly growing Genekor Medical S.A., a leading Greek company in molecular diagnostics in Europe, and Varus D.O.O.E.L., a pioneer in the healthcare sector in North Macedonia, announce their strategic alliance to promote Precision Medicine and reshape the landscape of oncological treatment in North Macedonia.
“We are particularly excited to collaborate with Varus D.O.O.E.L. to expand the frontiers of molecular science in Skopje,” said Nikos Tsoulos, CEO of Genekor Medical S.A. “This strategic alliance reflects our shared vision to harness the power of molecular diagnostics, delivering meaningful and innovative solutions to cancer patients.”
At the heart of this collaboration lies early diagnosis and personalized therapeutic approaches. Additionally, both companies aim to improve the effectiveness and cost-efficiency of healthcare solutions.
This strategic alliance marks a significant step forward in strengthening oncological care in North Macedonia, bringing the latest advances in molecular science closer to the patients who need them most.
Genekor Medical S.A. is a pioneering Greek company with offices in eight European countries and one of the leading and most innovative molecular diagnostics companies in Europe, specializing in personalized cancer treatment. With a strong focus on Precision Medicine, the company offers cutting-edge diagnostic technologies that contribute to the early detection and more effective management of cancer, ultimately improving patient clinical outcomes.
Varus D.O.O.E.L. is one of the first private companies in North Macedonia engaged in the trade of pharmaceutical, medical, and laboratory products. Founded in 1990 as the exclusive representative of Merck KGaA, today it has a presence in North Macedonia, Albania, and Kosovo. The company focuses on innovation and strategic partnerships, aiming to improve patients’ quality of life and strengthen the healthcare sector.